Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB)

CUSIP: 984241109

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
45,101,565
Total 13F shares
23,585,540
Share change
-1,234,947
Total reported value
$340,103,128
Price per share
$14.42
Number of holders
95
Value change
-$17,897,969
Number of buys
42
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 984241109?
CUSIP 984241109 identifies YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) as of Q3 2022

As of 30 Sep 2022, Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) was held by 95 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,585,540 shares. The largest 10 holders included BlackRock Inc., Polar Capital Holdings Plc, Sofinnova Investments, Inc., ALLIANCEBERNSTEIN L.P., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, STATE STREET CORP, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, and BIOIMPACT CAPITAL LLC. This page lists 95 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
90
Q3 2022 holders
95
Holder diff
5
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 Value $ Q3 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .